Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The primary objective is to evaluate pharmacokinetics of HRS-1893 tablets in subjects with impaired kidney function in comparison with healthy subjects, to develop dose recommendations for patients with renal impairment.
Epistemonikos ID: 6d817c48f94b77a2397edfb5a5c15233ea63015e
First added on: Feb 01, 2025